Mirum Pharmaceuticals MIRM
NASDAQ MIRM
$94.61 +0.19 (+0.20%)
As of: Nov 11, 2026 · 9:33 AM EST

Mirum Pharmaceuticals (MIRM) Return on Equity [ROE] (2019 - 2026)

Updated

Mirum Pharmaceuticals (MIRM) recorded Return on Equity [ROE] of -741.33% in Q2 2026, down 717.35 percentage points from -23.98% a year earlier and down 454.59 percentage points from the prior quarter.

Analysis

Mirum Pharmaceuticals (MIRM) Return on Equity [ROE] (2019 - 2026) Analysis & Trends

For FY2025, Mirum Pharmaceuticals reported Return on Equity [ROE] of -8.65%, up 28.43 percentage points from FY2024.

  • Annual Return on Equity [ROE] has increased for three straight years, with a five-year change of +59.64 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Equity [ROE] came in at -37.08% in FY2024 (+46.57 pp), -83.65% in FY2023 (+19.81 pp), -103.46% in FY2022 (-46.00 pp) and -57.47% in FY2021 (+10.82 pp).
  • The Q2 2026 figure is the lowest quarterly Return on Equity [ROE] in data going back to Q4 2019.
  • On a year-over-year basis, Return on Equity [ROE] rose in six of the last eight quarters, with an average year-over-year change of -97.58 percentage points.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 205.20 percentage points in Q3 2022, against a drop of 717.35 percentage points in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at -286.74% (Q1 2026), -7.70% (Q4 2025) and -15.14% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Mirum Pharmaceuticals 6.16 Bn 4.58 Bn 150.55 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -741.33%
Mar 31, 2026 -286.74%
Dec 31, 2025 -7.70%
Sep 30, 2025 -15.14%
Jun 30, 2025 -23.98%
Mar 31, 2025 -33.71%
Dec 31, 2024 -38.43%
Sep 30, 2024 -43.30%
Jun 30, 2024 -47.09%
Mar 31, 2024 -65.62%
Dec 31, 2023 -63.12%
Sep 30, 2023 -94.44%
Jun 30, 2023 -160.45%
Mar 31, 2023 -91.24%
Dec 31, 2022 -87.15%
Sep 30, 2022 -29.78%
Jun 30, 2022 -48.35%
Mar 31, 2022 -61.15%
Dec 31, 2021 -95.11%
Sep 30, 2021 -234.97%
API Access

Mirum Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MIRM&period=max&api_key=YOUR_API_KEY